Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Raynaud's Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02228850
What this trial is testing

Study of Acute Peripheral Vascular Effects, Safety and Tolerability in Subjects With Raynaud's Phenomenon Secondary to Systemic Sclerosis

Who this might be right for
Raynaud's Phenomenon Secondary to Systemic Sclerosis
NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.) 35
Not applicableStudy completedNCT00946738
What this trial is testing

The Effect of Physical Therapy on Raynaud's Phenomenon Secondary to Systemic Sclerosis

Who this might be right for
Raynaud's PhenomenonSystemic Sclerosis
Charite University, Berlin, Germany 28
Large-scale testing (Phase 3)Study completedNCT00266669
What this trial is testing

Phase III Study of Topical Gel for Treatment and Prevention of Raynaud's Phenomenon

Who this might be right for
Raynaud's Disease
MediQuest Therapeutics 200
Testing effectiveness (Phase 2)Ended earlyNCT01315899
What this trial is testing

Efficacy of ORM-12741 for Prevention of Raynaud's Phenomenon

Who this might be right for
Raynaud's Phenomenon
Orion Corporation, Orion Pharma 15
Not applicableWithdrawnNCT04898036
What this trial is testing

Phototherapy For Treatment Of Raynaud's Phenomenon

Who this might be right for
Raynaud DiseaseRaynaud PhenomenonRaynaud Syndrome
University of Minnesota
Large-scale testing (Phase 3)Study completedNCT00498615
What this trial is testing

A Rho-kinase Inhibitor (Fasudil) in the Treatment of Raynaud's Phenomenon

Who this might be right for
RaynaudScleroderma
Johns Hopkins University 17
Not applicableStudy completedNCT02396238
What this trial is testing

Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR)

Who this might be right for
SclerodermaSystemic SclerosisRaynaud Phenomena+1 more
Cytori Therapeutics 88
Not applicableUnknownNCT03749577
What this trial is testing

Nutritional Strategies to Increase Nitric Oxide Signaling in Raynaud's Phenomenon

Who this might be right for
Raynaud Phenomenon
University Hospital, Grenoble 30
Not applicableUnknownNCT04015193
What this trial is testing

Follow-up of SPTS in Patients With Raynaud's Phenomenon

Who this might be right for
Raynaud Phenomenon
University Medical Center Groningen 50
Testing effectiveness (Phase 2)Study completedNCT01926847
What this trial is testing

Digital Flow Enhancement in Raynaud's Phenomenon With an sGC (Soluble Guanylate Cyclase) Stimulator

Who this might be right for
Raynaud Disease
Bayer 23
Not applicableEnded earlyNCT03869008
What this trial is testing

Potential Benefit for Non Invasive Vagus Nerve Stimulation Using GammaCore in the Treatment of Raynaud's Phenomena.

Who this might be right for
Raynaud PhenomenonPrimary Raynaud PhenomenonRaynaud Disease+1 more
University of Toledo Health Science Campus 6
Post-approval studies (Phase 4)Study completedNCT05125029
What this trial is testing

Botulinum Toxin in Raynaud's Phenomenon

Who this might be right for
Raynaud Phenomenon
Emory University 24
Post-approval studies (Phase 4)Not Yet RecruitingNCT07240649
What this trial is testing

Emerging Indications for Hyperbaric Oxygen Treatment

Who this might be right for
Post-COVID-19 ConditionUlcerative ColitisCrohn Disease+38 more
Jay C. Buckey Jr. 100
Very early researchStudy completedNCT02583789
What this trial is testing

Assess Efficacy of of Oral Treprostinil in Patients With Symptomatic Primary or Secondary Raynaud's Phenomenon

Who this might be right for
Raynaud's Phenomenon
Brigham and Women's Hospital 12
Large-scale testing (Phase 3)Study completedNCT01291199
What this trial is testing

Effects of Vardenafil on Clinical Symptoms and Peripheral Blood Flow in Patients With Raynaud's Syndrome

Who this might be right for
Raynaud Syndrome
University of Cologne 57
Large-scale testing (Phase 3)UnknownNCT00934427
What this trial is testing

Study of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon Symptoms

Who this might be right for
Raynaud Disease
MediQuest Therapeutics 100
Large-scale testing (Phase 3)Study completedNCT02050360
What this trial is testing

"As Required" Oral Sildenafil in Raynaud's Phenomenon

Who this might be right for
Raynaud's Phenomenon
University Hospital, Grenoble 41
Not applicableStudy completedNCT04854850
What this trial is testing

Apollo Device for Fatigue in Systemic Sclerosis

Who this might be right for
Systemic SclerosisFatigueRaynaud Phenomenon
Robyn T. Domsic, MD, MPH 25
Not applicableUnknownNCT03984422
What this trial is testing

Application for Monitoring and Evaluation of Raynaud's Phenomenon

Who this might be right for
Raynaud Phenomenon
University Hospital, Grenoble 120
Large-scale testing (Phase 3)Study completedNCT00253331
What this trial is testing

Lab Study of MQX-503 in Treatment of Raynaud's

Who this might be right for
Raynaud DiseaseRaynaud Disease Secondary to SclerodermaRaynaud Secondary to Other Autoimmune Disease
MediQuest Therapeutics 36
Next Page